Related Experiment Videos

Present status of biological response modifiers in cancer

D R Parkinson¹

¹National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20852, USA.

The American Journal of Medicine

|December 29, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Educating for personalized medicine: a perspective from oncology.

Clinical pharmacology and therapeutics·2009

Anticancer drug discovery and development throughout the world.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2002

Immunodominance across HLA polymorphism: implications for cancer immunotherapy.

Journal of immunotherapy (Hagerstown, Md. : 1997)·1998

High-dose aldesleukin in renal cell carcinoma: long-term survival update.

The cancer journal from Scientific American·1998

Antisense oligonucleotides as therapeutics for malignant diseases.

Seminars in oncology·1997

Clinical implications of tumor-associated neovascularization and current antiangiogenic strategies for the treatment of malignancies of pancreas.

Cancer·1996

See all related articles